Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Roskrow

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Klinische Padiatrie|September 3, 1999
Tumor vaccines--application to childhood cancerM A Roskrow, A Zibert, M Souquet, et al.
European Journal of Immunology|March 10, 2001
The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin diseaseZ Su, M V Peluso, S H Raffegerst, et al.
Bone Marrow Transplantation|November 1, 1992
Selective automatic neuropathy as a novel complication of BMTM A Roskrow, S M Kelsey, M McCarthy, et al.
Journal of the National Cancer Institute. Monographs|August 26, 1998
Immunotherapy for Epstein-Barr virus-associated cancersC M Rooney, M A Roskrow, C A Smith, et al.
Leukemia Research|June 22, 1999
Autoimmune disease induced by dendritic cell immunization against leukemiaM A Roskrow, D Dilloo, N Suzuki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 1999
Treatment of relapsed Hodgkin's disease using EBV-specific cytotoxic T cellsC M Rooney, M A Roskrow, N Suzuki, et al.
Genomics|February 1, 1997
The human erythroid-specific transcription factor EKLF localizes to chromosome 19p13.12-p13.13J H van Ree, M A Roskrow, A M Becher, et al.
Blood|May 16, 1998
Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's diseaseM A Roskrow, N Suzuki, Y j Gan, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Klinische Padiatrie|September 3, 1999
Tumor vaccines--application to childhood cancerM A Roskrow, A Zibert, M Souquet, et al.
European Journal of Immunology|March 10, 2001
The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin diseaseZ Su, M V Peluso, S H Raffegerst, et al.
Bone Marrow Transplantation|November 1, 1992
Selective automatic neuropathy as a novel complication of BMTM A Roskrow, S M Kelsey, M McCarthy, et al.
Journal of the National Cancer Institute. Monographs|August 26, 1998
Immunotherapy for Epstein-Barr virus-associated cancersC M Rooney, M A Roskrow, C A Smith, et al.
Leukemia Research|June 22, 1999
Autoimmune disease induced by dendritic cell immunization against leukemiaM A Roskrow, D Dilloo, N Suzuki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 1999
Treatment of relapsed Hodgkin's disease using EBV-specific cytotoxic T cellsC M Rooney, M A Roskrow, N Suzuki, et al.
Genomics|February 1, 1997
The human erythroid-specific transcription factor EKLF localizes to chromosome 19p13.12-p13.13J H van Ree, M A Roskrow, A M Becher, et al.
Blood|May 16, 1998
Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's diseaseM A Roskrow, N Suzuki, Y j Gan, et al.
Pageof 1